Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000154551 | SCV000168104 | benign | not specified | 2015-03-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory for Molecular Medicine, |
RCV000154551 | SCV000204224 | benign | not specified | 2010-12-17 | criteria provided, single submitter | clinical testing | Glu108Glu in Exon 01 of DES: This variant is not expected to have clinical signi ficance because it does not alter an amino acid residue, is not located within t he splice consensus sequence and has been identified in 0.5% (20/3706) of Africa n American chromosomes from a broad population by the NHLBI Exome Sequencing Pro ject (http://evs.gs.washington.edu/EVS; dbSNP rs138677215). |
Eurofins Ntd Llc |
RCV000154551 | SCV000224365 | benign | not specified | 2014-12-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000226557 | SCV000287222 | benign | Desmin-related myofibrillar myopathy | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000154551 | SCV000308537 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000250330 | SCV000320422 | likely benign | Cardiovascular phenotype | 2015-11-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV001529031 | SCV001159645 | benign | not provided | 2023-11-06 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000154551 | SCV002548219 | benign | not specified | 2022-05-07 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001529031 | SCV001741797 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000154551 | SCV001918123 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001529031 | SCV001964294 | likely benign | not provided | no assertion criteria provided | clinical testing |